According to the brand’s historical records, Scholl patented his first arch-support invention in 1904 before establishing the Dr Scholl’s company in 1906.2

The origins of Dr Scholl’s are tied to William Mathias Scholl (1882–1968). Born on 22 June 1882 in La Porte, Indiana, Scholl came from a large family with shoemaking roots; his grandfather was a German cobbler. He became familiar with footwear construction and repair from a young age and, at 16, left the family farm to apprentice at a shoemaker’s shop in Chicago.1

During his apprenticeship, Scholl observed frequent complaints regarding foot pain and discomfort, which sparked an interest in foot anatomy and medical treatment. He later studied medicine at the institution that became Loyola University Chicago, earning his M.D. in 1904. Rather than establishing a conventional medical practice, he applied his medical training specifically to footwear and foot-support technology.3 This synthesis of medicine, footwear design, and engineering formed the foundational philosophy of the brand.

In 1904, while still a student, Scholl patented his first arch-support invention. The concept focused on supporting the arch of the foot from within the shoe, serving as the commercial foundation for his future enterprise. Two years later, in 1906, he founded the Dr Scholl’s company to manufacture and sell foot-care products.2 Unlike fashion-focused footwear brands, the company’s early identity centred on resolving physical problems associated with the human foot.

Scholl built the business on the premise that foot health impacts overall well-being, encapsulated by the historical phrase: “When your feet hurt, you hurt all over.” This perspective helped transform foot care from a niche medical concern into a matter of everyday comfort and mobility. Over his lifetime, Scholl was responsible for bringing more than 1,000 foot-care products to market.4

A significant innovation of Dr Scholl’s was the translation of foot science into a consumer brand. Instead of requiring specialist visits for minor ailments, the company developed products accessible for home use with ordinary footwear. The product range eventually expanded beyond arch supports to include:

• Insoles and arch supports
• Shoe inserts and foot cushions
• Corn, callus, and wart treatments
• Blister protection and bunion products
• Foot odour and moisture control products
• Foot files and care devices
• Footwear and mobility aids

The modern company describes its mission as helping people “move better from the ground up”.3

Historically, ownership and trademark rights were divided geographically, leading to distinct branding in different regions. For decades, the brand was marketed as Dr Scholl’s in the Americas and as Scholl in international markets. According to Yellow Wood, these rights had been separated for more than 30 years prior to reunification.5 Consequently, consumers in Singapore and other international markets may be more familiar with the Scholl name, while North American consumers recognise Dr Scholl’s.

Dr Scholl’s has undergone several major changes in corporate ownership throughout its history.

Independent era and Schering-Plough

William Scholl grew the business from his original inventions into an international company. In 1979, Schering-Plough acquired the Dr Scholl’s brand. When Merck acquired Schering-Plough in 2009, Dr Scholl’s became part of Merck & Co.4

Bayer acquisition

In 2014, Bayer acquired Merck’s consumer-health business, integrating the Americas Dr Scholl’s operations into Bayer Consumer Health.2

Sale to Yellow Wood Partners

In November 2019, Bayer completed the sale of the Dr Scholl’s business to Yellow Wood Partners for US$585 million. At the time of sale, Bayer reported the business had generated US$234 million in sales in 2018.2 Yellow Wood established Scholl’s Wellness Company as a standalone organisation to operate the Americas business.

Global reunification

In June 2021, Yellow Wood acquired the international Scholl business from Reckitt. This transaction reunited the international and American businesses, creating an integrated global foot-care company operating in over 50 countries with annual retail sales exceeding US$700 million at the time.1113

Today, Scholl’s Wellness Company serves as the parent entity for the Dr Scholl’s brand and is owned by Boston-based private-equity firm Yellow Wood Partners.17 In March 2025, the company appointed Meghan Davis as CEO, with a stated strategy of accelerating global growth and continuing to unify the brand worldwide.18

Expansion has continued under this leadership. In May 2026, Scholl’s Wellness Company acquired VKTRY, a performance-insole and footwear technology brand specialising in carbon-fibre products for athletic performance.5 This acquisition signals a strategic shift beyond traditional foot-pain relief towards performance, mobility, and broader foot wellness.

The brand’s current portfolio encompasses several key categories.

Insoles and inserts

Insoles remain the category most strongly associated with Dr Scholl’s. Products are designed for specific activities and needs, including everyday walking, prolonged standing, work, running, heel pain, arch support, shock absorption, fatigue reduction, cushioning, and odour control. Current offerings include Advanced Pain Relief Insoles, 24-Hour Energy Insoles, Walk Longer Insoles, and Work Insoles with Massaging Gel.6

Foot pain and comfort

Products in this category address specific sources of discomfort such as heel pain, tired or aching feet, pressure points, blisters, bunions, corns, and calluses. The approach focuses on treating discomfort at the foot level rather than viewing footwear solely as a fashion accessory.7

Skin treatments

Foot skin care constitutes a significant portion of the portfolio, featuring treatments and tools for warts, corns, calluses, hard or dry skin, cracked feet, and blisters. Current products include Freeze Away, foot files, and various skin-treatment solutions.8

Odour and perspiration control

The brand offers sprays, powders, and odour-fighting insoles aimed at controlling foot odour, excessive wetness, sweat, and odour within footwear.6

Foot-care devices

Beyond passive products, the company manufactures electronic and mechanical devices such as the Pedi Perfect Electronic Foot File, designed to remove hard skin and improve foot appearance.8

Dr Scholl’s positions its products as engineered solutions rather than simple accessories. Key technological emphases include biomechanics, cushioning, shock absorption, arch support, pressure distribution, energy return, fatigue reduction, and foot stability. Technologies such as Massaging Gel® are marketed to provide cushioning and shock absorption, while newer innovations focus on energy return and structural support.9 This places the brand at the intersection of consumer healthcare, footwear technology, and personal wellness.

Insoles represent the modern expression of William Scholl’s original concept: modifying how the foot interacts with the shoe’s outer structure to alter cushioning, support, impact, pressure distribution, positioning, and fatigue perception.

Dr Scholl’s occupies a distinct position between performance footwear brands like Nike or Adidas and professional podiatric care. It focuses on everyday foot health, comfort, and accessible technology, with a consumer promise centred on enabling movement through improved foot comfort.10 Unlike specialist medical brands, Dr Scholl’s targets common issues such as everyday discomfort, fatigue, odour, and minor skin conditions, making foot-care technology accessible to general consumers.

While Dr Scholl’s is prominent as a foot-care and insole brand, the broader Scholl heritage includes footwear designed around comfort and anatomy, such as the historically significant Pescura sandal. Modern Scholl footwear continues to combine comfort technology with fashion-oriented designs, though product assortments vary by country.19

The brand’s evolution can be categorised into four distinct periods:

• Medical innovation (1904–mid-20th century): Built on Scholl’s medical knowledge and arch-support inventions.
• Mass-market foot care (mid-20th century–1980s): Expansion into a household name with a broad consumer product range.
• Multinational ownership (1980s–2019): Ownership by Schering-Plough, Merck, and Bayer, alongside separate international rights.
• Independent global company (2019–present): Acquisition by Yellow Wood, creation of Scholl’s Wellness Company, and reunification of global businesses, with expansion into wellness and performance.11

In 1947, William Scholl established the Dr. Scholl Foundation, an independent charitable organisation funded by his business success. Upon his death in 1968, he bequeathed most of his estate to the foundation. Since 1980, the foundation has contributed more than $312 million to various organisations. It remains separate from the modern commercial Dr Scholl’s business.12

Following the 2021 combination, the Dr Scholl’s/Scholl organisation operates in over 50 countries, with strong market positions in Europe, Australia, and the Americas.13 The brand name varies by region: Dr Scholl’s is used in the United States and much of the Americas, while Scholl is used in many international markets, including Singapore. Despite the naming difference, both trace back to the same founder and now share a unified ownership structure.

Six factors define the brand’s competitive identity:

1. Heritage: Origins dating to 1904/1906 provide over a century of category history.
2. Founder credibility: William Scholl combined medical education with practical shoemaking knowledge.
3. Accessibility: Transformation of professional foot health into everyday consumer products.
4. Category association: Strong linkage to specialised in-shoe support.
5. Product ecosystem: Breadth spanning pain relief, skin care, odour control, footwear, and devices.
6. Global reunification: The 2021 merger of the previously separated American and international businesses.14

In 2026, Dr Scholl’s functions as a broader foot-health and mobility platform rather than solely an insole company. While its core remains rooted in comfort and support, the brand is expanding into skin care, wellness, performance, and mobility. The acquisition of VKTRY illustrates this shift from traditional consumer foot care towards high-performance athletic insoles and footwear technology.5

• 1882: William Mathias Scholl born in Indiana.
• 1904: Scholl patents first arch-support invention.
• 1906: Dr Scholl’s company founded in Chicago.
• 1947: Dr. Scholl Foundation established.
• 1968: William Scholl dies.
• 1979: Schering-Plough acquires the brand.
• 2009: Brand becomes part of Merck following Schering-Plough acquisition.
• 2014: Bayer acquires consumer-health business containing Dr Scholl’s Americas.2
• 2019: Bayer sells Dr Scholl’s Americas to Yellow Wood Partners for US$585 million.1516
• 2021: Yellow Wood acquires international Scholl from Reckitt, reunifying global businesses.11
• 2025: Meghan Davis appointed CEO of Scholl’s Wellness Company.18
• 2026: Scholl’s Wellness Company acquires performance-insole company VKTRY.5

1. About Dr. William Scholl – DrScholls
2. Bayer completes sale of Dr. Scholl’s™ brand to Yellow Wood Partners
3. Our Purpose – DrScholls
4. Dr. Scholl’s
5. YellowWood – Taking the Road Less Traveled in Private Equity. | May 20 2026
6. Dr. Scholl’s® Shoe Inserts, Insoles, & Orthotics – DrScholls
7. Relieve The Pressure – DrScholls
8. Dr. Scholls Teams Up with Sportscaster Erin Andrews on her Road to the – Tagged “” – DrScholls
9. Terms and Conditions – DrScholls
10. Hart v. Scholl’s Wellness Company, LLC et al 2:2021cv00497 | U.S. District Court for the Eastern District of Virginia | Justia
11. Yellow Wood Partners Announces Completion of Scholl Acquisition
12. Yellow Wood Partners Announces Completion of Scholl Acquisition – DrScholls
13. Yellow Wood Partners to Acquire Scholl From Reckitt Benckiser
14. Yellow Wood Partners to Acquire Scholl From Reckitt Benckiser – DrScholls
15. Dr. Scholls Partners with Nine-time Olympic Track and Field Medalist, – Tagged “” – DrScholls
16. Bayer schließt Verkauf von Dr. Scholl’s an Yellow Wood Partners ab
17. Yellow Wood Partners, LLC | LinkedIn
18. We are thrilled to announce the appointment of Meghan Davis as the new CEO of Scholl’s Wellness Company!   Meghan brings over a decade of experience in consumer products and a track record of… | Yellow Wood Partners, LLC
19. About Us | Dr. Scholl’s Shoes